However, previous study suggested that genetically adjusted PSA was more predictive of high-risk PCa compared to unadjusted PSA (AUC: 0.755 vs. 0.738), thus avoiding a large number of unnecessary biopsies (Kachuri et al., 2023). Here, KLK3 is linked to posterior cortical atrophy.